← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Medigen, Inc.
Frederick, MD
$10,326,929
Total funding
12
Grants
Funding over time
peak $2.2M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,326,929 · 12
By mechanism
N01$2,181,107 · 1
U01$1,876,310 · 1
R44$1,624,180 · 1
R01$1,526,376 · 1
N44$1,483,094 · 1
R43$1,371,691 · 5
Investigators at Medigen, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
DEVELOPMENT OF A LASSA FEVER VIRUS VACCINE$2,181,107
N01 · FY2025 · AI
SBIR TOPIC 255, PHASE II: SYNTHETIC VACCINES AGAINST PROSTATE CANCER$1,483,094
N44 · FY2011 · CA
Novel DNA-Launched Attenuated Vaccine for VEE Virus SBIR Phase II$812,615
R44 · FY2017 · AI
Novel DNA-Launched Attenuated Vaccine for VEE Virus SBIR Phase II$811,565
R44 · FY2016 · AI
Safety and Immunogenicity of novel, live-attenuated V4020 vaccine for Venezuelan Equine Encephalitis (VEE) in healthy adults$709,235
U01 · FY2022 · AI
Safety and Immunogenicity of novel, live-attenuated V4020 vaccine for Venezuelan Equine Encephalitis (VEE) in healthy adults$604,508
U01 · FY2023 · AI
Safety and Immunogenicity of novel, live-attenuated V4020 vaccine for Venezuelan Equine Encephalitis (VEE) in healthy adults$562,567
U01 · FY2024 · AI
Broad-Range VLP Vaccine Against H5N1 Influenza$400,757
R01 · FY2015 · AI
Broad-Range VLP Vaccine Against H5N1 Influenza$392,210
R01 · FY2016 · AI
Broad-Range VLP Vaccine Against H5N1 Influenza$383,409
R01 · FY2017 · AI
Broad-Range VLP Vaccine Against H5N1 Influenza$350,000
R01 · FY2014 · AI
Novel DNA-Launched Attenuated Vaccine for VEE Virus$300,000
R43 · FY2011 · AI
Novel DNA-Launched Attenuated Vaccine for VEE Virus$300,000
R43 · FY2012 · AI
Trivalent Arenaviral Vaccine Based on Virus-Like Particle Vectors (VLPVs)$222,146
R43 · FY2011 · AI
Novel Chikungunya vaccine with rearranged genome$120,759
R43 · FY2020 · AI
Novel Chikungunya vaccine with rearranged genome$120,042
R43 · FY2021 · AI
Infectious DNA (i-DNA) Vaccine for Yellow Fever$117,986
R43 · FY2011 · AI
Multivalent emergency vaccine against pandemic influenza$95,379
R43 · FY2018 · AI
Multivalent emergency vaccine against pandemic influenza$95,379
R43 · FY2019 · AI
SBIR TOPIC 255$89,871
N43 · FY2009 · CA